(Q45864761)

17 December 2017

title

Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy (English)

1 reference

17 December 2017

1 reference

Ahmed A

1

1 reference

17 December 2017

Jevremovic D

2

1 reference

17 December 2017

Suzuki K

3

1 reference

17 December 2017

Kottke T

4

1 reference

17 December 2017

Thompson J

5

1 reference

17 December 2017

Emery S

6

1 reference

17 December 2017

Harrington K

7

1 reference

17 December 2017

Bateman A

8

1 reference

17 December 2017

Vile R

9

1 reference

17 December 2017

language of work or name

1 reference

1 September 2003

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

10

1 reference

17 December 2017

issue

19

1 reference

17 December 2017

page(s)

1663-1671

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302064

exact match

0 references

cites work

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

Replicative adenoviruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

Vironcology-not yet, but soon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

Replication-selective viruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to consider

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

Cancer gene therapy by adenovirus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

Human immunodeficiency virus type 1-mediated syncytium formation is compatible with adenovirus replication and facilitates efficient dispersion of viral gene products and de novo-synthesized virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the ADP region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

A system for small-molecule control of conditionally replication-competent adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302064

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302064

1 reference

17 December 2017

Dimensions Publication ID

1051568151

0 references

1 reference

17 December 2017